|
ZNF624 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.759500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.036600E-03 |
| Normal-vs-Stage2 |
1.003780E-01 |
| Normal-vs-Stage3 |
1.615950E-04 |
| Normal-vs-Stage4 |
4.67000000003992E-06 |
| Stage1-vs-Stage2 |
8.622600E-01 |
| Stage1-vs-Stage3 |
5.943500E-02 |
| Stage1-vs-Stage4 |
1.924350E-03 |
| Stage2-vs-Stage3 |
5.012200E-01 |
| Stage2-vs-Stage4 |
2.506200E-01 |
| Stage3-vs-Stage4 |
3.531400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.238800E-04 |
| Normal-vs-AfricanAmerican |
8.968300E-04 |
| Normal-vs-Asian |
9.887000E-01 |
| Caucasian-vs-AfricanAmerican |
3.147000E-01 |
| Caucasian-vs-Asian |
2.054000E-01 |
| AfricanAmerican-vs-Asian |
8.004300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.419700E-04 |
| Normal-vs-Female |
1.158580E-03 |
| Male-vs-Female |
5.126600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.654640E-01 |
| Normal-vs-Age(41-60Yrs) |
2.543600E-02 |
| Normal-vs-Age(61-80Yrs) |
5.86909999999996E-05 |
| Normal-vs-Age(81-100Yrs) |
7.412100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.594800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.454590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.849600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.942180E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.636500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.160230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.850800E-01 |
| Normal-vs-Grade 2 |
8.832100E-02 |
| Normal-vs-Grade 3 |
2.37309999999713E-05 |
| Normal-vs-Grade 4 |
2.27760000004462E-06 |
| Grade 1-vs-Grade 2 |
7.343600E-01 |
| Grade 1-vs-Grade 3 |
4.102300E-02 |
| Grade 1-vs-Grade 4 |
1.374170E-02 |
| Grade 2-vs-Grade 3 |
1.419700E-03 |
| Grade 2-vs-Grade 4 |
2.408200E-04 |
| Grade 3-vs-Grade 4 |
2.112400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.221800E-02 |
| Normal-vs-ccB subtype |
7.570300E-04 |
| ccA subtype-vs-ccB subtype |
9.553800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.478500E-03 |
| Normal-vs-N1 |
6.735500E-02 |
| N0-vs-N1 |
7.760400E-01 |
|
|
